Immunology News and Research

Latest Immunology News and Research

Antibiotics may increase incidence and severity of allergic asthma in early life

Widely used antibiotics may increase incidence and severity of allergic asthma in early life, according to a University of British Columbia study.

17 Mar 2012

UAB researchers develop new vehicle to release proteins with therapeutic effects

UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria.

17 Mar 2012

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott today announced the initiation of two Phase 3 clinical trials designed to evaluate the safety and efficacy of an investigational use of HUMIRA (adalimumab) in adult patients with moderate to severe hidradenitis suppurativa.

16 Mar 2012

Linking HCV infected people with care is key to reducing related mortality and morbidity

Broader screening to identify people infected with hepatitis C virus (HCV) would likely be cost effective, according to a new report published in Clinical Infectious Diseases.

15 Mar 2012

CUMC scientists develop a way to recreate personalized immune mouse

Columbia University Medical Center (CUMC) scientists have developed a way to recreate an individual's immune system in a mouse. The "personalized immune mouse" offers researchers an unprecedented tool for individualized analysis of abnormalities that contribute to type 1 diabetes and other autoimmune diseases, starting at the onset of disease.

15 Mar 2012

Scientists discover direct biomarker of Chikungunya fever

Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore Immunology Network (SIgN) have made great strides in the battle against the infectious disease.

15 Mar 2012

Scientists discover cells that chaperone food antigens in the intestine

With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass. Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the intestine so that the immune system doesn't mount an attack.

15 Mar 2012

UCSF's School of Pharmacy ranks first and School of Medicine ranks third in nationwide survey

UCSF's School of Pharmacy ranked first in its field this year, while its School of Medicine tied for third place nationwide, according to a new survey conducted by U.S. News & World Report.

14 Mar 2012

Another role for protein Mer in novel, targeted cancer treatments

Since the mid-1990s, doctors have had the protein Mer in their sights - it coats the outside of cancer cells, transmitting signals inside the cells that aid their uncontrolled growth.

14 Mar 2012

FDA panel favors continued research on novel pain medicine

A panel of experts for the U.S. Food and Drugs Administration (FDA) this Monday recommended that the federal government should allow continued testing of an experimental class of pain drugs for arthritis, despite links to bone decay and joint failure.

13 Mar 2012

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Inovio Pharmaceuticals, Inc. announced today that it has achieved strong T cell immune responses in a Phase I clinical study of PENNVAX-B, its product for the treatment of the HIV subtype prevalent in North America and Europe, in HIV-positive subjects.

13 Mar 2012

Trudeau Institute creates TICRO to expand the scope of biomedical research

The Trudeau Institute announced today that it has expanded the scope of its biomedical research by creating a contract research organization (CRO), the Trudeau Institute Contract Research Organization.

13 Mar 2012

Study addresses how human body controls gamma-herpesviruses

New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology.

13 Mar 2012

Researchers unlock mystery of how an inflammatory molecule is produced in the body

Cedars-Sinai researchers have unlocked the mystery of how an inflammatory molecule is produced in the body, a discovery they say could lead to advances in the treatment of rheumatoid arthritis, Type 2 diabetes and numerous other chronic diseases that affect tens of millions of people.

12 Mar 2012

OPKO Health, Scripps Research partner to commercialize Parkinson's disease compound, SR 3306

The Scripps Research Institute and OPKO Health, Inc. today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson's disease.

12 Mar 2012

Researchers identify genetic signature for eosinophilic esophagitis

Researchers have identified a genetic signature for a severe, often painful food allergy – eosinophilic esophagitis – that could lead to improved diagnosis and treatment for children unable to eat a wide variety of foods.

12 Mar 2012

HDAC inhibitors flush latent HIV infection from hiding

A team of researchers at the University of North Carolina at Chapel Hill have successfully flushed latent HIV infection from hiding, with a drug used to treat certain types of lymphoma.

9 Mar 2012

Doctor associated with MMR vaccine and autism link wins High Court appeal

Professor John Walker-Smith had been found guilty of professional misconduct following claims he took part in unapproved research that suggested links between the vaccine, bowel disease and autism. Professor Walker-Smith lost his license to practice in May 2010 along with Dr Andrew Wakefield, who led the research. A General Medical Council’s ‘fitness to practice’ panel found both men guilty of misconduct over the way the work was conducted after 217 days of deliberation – the longest disciplinary case in the body’s 150- year history.

8 Mar 2012

Bellicum raises $20M in Series B financing

Bellicum Pharmaceuticals, Inc. today announced that it has raised $20 million in a Series B financing. The funding will be used to advance its lead CaspaCIDe and DeCIDe programs through Phase 2 clinical development.

8 Mar 2012

Positive phase II trial results from Circassia's ragweed allergy therapy

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that its ragweed allergy therapy has achieved positive results in a key phase II clinical trial.

8 Mar 2012

Immunology News and Research

Latest Immunology News and Research

Antibiotics may increase incidence and severity of allergic asthma in early life

UAB researchers develop new vehicle to release proteins with therapeutic effects

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Linking HCV infected people with care is key to reducing related mortality and morbidity

CUMC scientists develop a way to recreate personalized immune mouse

Scientists discover direct biomarker of Chikungunya fever

Scientists discover cells that chaperone food antigens in the intestine

UCSF's School of Pharmacy ranks first and School of Medicine ranks third in nationwide survey

Another role for protein Mer in novel, targeted cancer treatments

FDA panel favors continued research on novel pain medicine

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Trudeau Institute creates TICRO to expand the scope of biomedical research

Study addresses how human body controls gamma-herpesviruses

Researchers unlock mystery of how an inflammatory molecule is produced in the body

OPKO Health, Scripps Research partner to commercialize Parkinson's disease compound, SR 3306

Researchers identify genetic signature for eosinophilic esophagitis

HDAC inhibitors flush latent HIV infection from hiding

Doctor associated with MMR vaccine and autism link wins High Court appeal

Bellicum raises $20M in Series B financing

Positive phase II trial results from Circassia's ragweed allergy therapy

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey